- Studies in cow’s milk allergy: results from the Dutch EuroPrevall birth cohort
- Award date
- 18 March 2016
- Number of pages
- Document type
- PhD thesis
- Faculty of Medicine (AMC-UvA)
Cow’s milk allergy is a common disease in infancy. However, until recently accurate numbers were not available. To investigate how many infants suffered from cow’s milk allergy, the EuroPrevall study was designed. In this European, multicentre study, nine European hospitals followed over 12,000 children from birth up to 2.5 years of age. All children with symptoms suspected of cow’s milk allergy were further evaluated according to international guidelines, including a double blind placebo-controlled food challenge.
Five percent of the Dutch children participating in this study had challenge proven cow’s milk allergy. While being treated for cow’s milk allergy, half of the children were not symptom free when using the standard cow’s milk protein free formula (extensively hydrolysed formula), but were symptom free after using an amino acid formula. This was more than expected.
Furthermore, some hereditary components for cow’s milk allergy were identified. A hypermethylation was found with epigenetic investigations in children with cow’s milk allergy compared to healthy age-matched controls. Second, 2 small genetic changes (SNP’s) were found more often in children with cow’s milk allergy compared to their healthy age-matched controls. These 2 changes were previously reported in asthma and allergic rhinitis. This might favour the allergic march hypothesis.
- Online version of the thesis without "Curriculum vitae" and "Dankwoord" (pp. 188-191).
Chapter 5 is the author’s version of a work that was accepted for publication in European Annals of Allergy and Clinical Immunology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in European Annals of Allergy and Clinical Immunology [VOL 46, ISSUE 1, PAGES 43-45; 2014].
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library, or send a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.